HAL (France)open access
Prevalence and direct costs of vestibular disease in France – matched case-control study results from the 2022 and 2023 french health data system
Healthcare costs, Prevalence of vestibular disorders, 0, Betahistine, Vestibular dysfunction
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 268618
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.